Company Filing History:
Years Active: 2000-2006
Title: Innovator Spotlight: Thomas L. Dufalla
Introduction
Thomas L. Dufalla is a notable inventor based in McMurray, Pennsylvania, recognized for his contributions to medical technology. With a total of two patents to his name, Dufalla has made significant advancements in the design and functionality of injector-actuated syringes.
Latest Patents
Dufalla's latest patents focus on innovative plunger systems designed for use in injector-actuated syringes. These systems incorporate a dynamic wedge seal that enhances the sealing engagement between the plunger cover and the syringe barrel. Additionally, the plunger features flexible capture members extending from its rear surface, allowing for the engagement and disengagement of the plunger from the injector drive means at any position within the syringe. Notably, these plunger systems include a contrast-saving tip that effectively expels the injection liquid from the syringe tip, showcasing Dufalla's commitment to improving medical device efficiency and effectiveness.
Career Highlights
Working at Medrad, Inc., Dufalla has played a pivotal role in the development of advanced medical devices. His innovative approach to problem-solving and extensive knowledge in the field have helped the company establish its reputation for producing high-quality medical equipment.
Collaborations
Throughout his career, Dufalla has collaborated with talented professionals, including colleagues Mark W. Hitchins and Edward J. Rhinehart. These partnerships have facilitated the exchange of ideas and expertise, ultimately contributing to the successful development of his patented technologies.
Conclusion
Thomas L. Dufalla's work exemplifies the spirit of innovation in the medical technology sector. His patents not only demonstrate his technical proficiency but also reflect his dedication to enhancing healthcare outcomes. As he continues to contribute to the field, it will be exciting to see how his inventive designs evolve and impact the industry.